A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD
Clinical trial NCT02918929 · COMPLETED
Trial details
- NCT number
- NCT02918929
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.